Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1986 Nov;45(11):950–953. doi: 10.1136/ard.45.11.950

Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids.

P N Sambrook, J A Eisman, M G Yeates, N A Pocock, S Eberl, G D Champion
PMCID: PMC1002026  PMID: 3789829

Abstract

Fear of inducing generalised osteoporosis is one reason why corticosteroids are withheld in patients with rheumatoid arthritis (RA). No studies, however, have directly measured bone density in such patients at clinically relevant sites. To assess this risk we measured bone mineral density in the lumbar spine and femoral neck by dual photon absorptiometry in 84 patients with RA, 44 of whom had been treated with low dose prednis(ol)one (mean dose +/- SE 8.0 +/- 0.5 mg/day; mean duration of treatment 89.6 +/- 12.0 months). There were significant reductions in bone mineral density in patients treated with corticosteroids (lumbar 9.6%, p less than 0.001; femoral 12.2%, p less than 0.001) and in those who had not received corticosteroids (lumbar 6.9%, p less than 0.01; femoral 8.9%, p less than 0.001), but the differences between the two groups were not significant. We conclude on the basis of these studies that low dose oral corticosteroids do not increase the risk of generalised osteoporosis in patients with rheumatoid arthritis.

Full text

PDF
950

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Als O. S., Gotfredsen A., Christiansen C. The effect of glucocorticoids on bone mass in rheumatoid arthritis patients. Influence of menopausal state. Arthritis Rheum. 1985 Apr;28(4):369–375. doi: 10.1002/art.1780280403. [DOI] [PubMed] [Google Scholar]
  2. Buchanan W. W., Samuels B. M., Jasani M. K., Anderson J. A., O'Brien W. M., Boyle J. A., Nuki G., Boyle I. T. Do oral corticosteroids cause osteoporosis in rheumatoid arthritis? Ann Rheum Dis. 1970 Sep;29(5):560–561. doi: 10.1136/ard.29.5.560-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Butler R. C., Goddard D. H. Controversy in the treatment of rheumatoid arthritis. Lancet. 1984 Aug 4;2(8397):278–279. doi: 10.1016/s0140-6736(84)90314-3. [DOI] [PubMed] [Google Scholar]
  4. D'Angelo A., Fabris A., Sartori L., Malvasi L., Travaglia P., Gambari P. F., Todesco S. Mineral metabolism and bone mineral content in rheumatoid arthritis. Effect of corticosteroids. Clin Exp Rheumatol. 1985 Apr-Jun;3(2):143–146. [PubMed] [Google Scholar]
  5. Guyatt G. H., Webber C. E., Mewa A. A., Sackett D. L. Determining causation--a case study: adrenocorticosteroids and osteoporosis. Should the fear of inducing clinically important osteoporosis influence the decision to prescribe adrenocorticosteroids? J Chronic Dis. 1984;37(5):343–352. doi: 10.1016/0021-9681(84)90100-0. [DOI] [PubMed] [Google Scholar]
  6. Hajiroussou V. J., Webley M. Prolonged low-dose corticosteroid therapy and osteoporosis in rheumatoid arthritis. Ann Rheum Dis. 1984 Feb;43(1):24–27. doi: 10.1136/ard.43.1.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kennedy A. C., Boddy K., Williams E. D., Elliott A. T., Harvey I., Holloway I., Haywood J. K. Whole body elemental composition during drug treatment of rheumatoid arthritis: a preliminary study. Ann Rheum Dis. 1979 Apr;38(2):137–140. doi: 10.1136/ard.38.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Krølner B., Pors Nielsen S. Measurement of bone mineral content (BMC) of the lumbar spine, I. Theory and application of a new two-dimensional dual-photon attenuation method. Scand J Clin Lab Invest. 1980;40(7):653–663. doi: 10.1080/00365518009091978. [DOI] [PubMed] [Google Scholar]
  9. MEEMA H. E. Cortical bone atrophy and osteoporosis as a manifestation of aging. Am J Roentgenol Radium Ther Nucl Med. 1963 Jun;89:1287–1295. [PubMed] [Google Scholar]
  10. Masi A. T. Low dose glucocorticoid therapy in rheumatoid arthritis (RA): transitional or selected add-on therapy? J Rheumatol. 1983 Oct;10(5):675–678. [PubMed] [Google Scholar]
  11. Million R., Kellgren J. H., Poole P., Jayson M. I. Long-term study of management of rheumatoid arthritis. Lancet. 1984 Apr 14;1(8381):812–816. doi: 10.1016/s0140-6736(84)92270-0. [DOI] [PubMed] [Google Scholar]
  12. Mueller M. N., Jurist J. M. Skeletal status in rheumatoid arthritis. A preliminary report. Arthritis Rheum. 1973 Jan-Feb;16(1):66–70. doi: 10.1002/art.1780160110. [DOI] [PubMed] [Google Scholar]
  13. Myles A. Corticosteroid treatment in rheumatoid arthritis. Br J Rheumatol. 1985 May;24(2):125–127. doi: 10.1093/rheumatology/24.2.125. [DOI] [PubMed] [Google Scholar]
  14. Reid D. M., Kennedy N. S., Smith M. A., Tothill P., Nuki G. Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J (Clin Res Ed) 1982 Jul 31;285(6338):330–332. doi: 10.1136/bmj.285.6338.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Saville P. D., Kharmosh O. Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids. Arthritis Rheum. 1967 Oct;10(5):423–430. doi: 10.1002/art.1780100504. [DOI] [PubMed] [Google Scholar]
  16. de Deuxchaisnes C. N., Devogelaer J. P., Esselinckx W., Bouchez B., Depresseux G., Rombouts-Lindemans C., Huaux J. P. The effect of low dosage glucocorticoids on bone mass in rheumatoid arthritis: a cross-sectional and a longitudinal study using single photon absorptiometry. Adv Exp Med Biol. 1984;171:209–239. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES